10X Genomics Inc Class A (TXG)

CapEx to Revenue

1.05%

Quarterly · Period ending:

TXG logo

TXG CapEx to Revenue

Latest reported1.05%
TXG Quarterly CapEx/Revenue (5.51% → 1.05%)
High-resolution chart · PNG

TXG capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.0514%
1.0587%
1.0703%
0.4611%
0.9126%
1.2222%
1.6459%
2.5644%
2.5329%
2.0637%
1.8752%
10.0466%
17.2702%
3.395%
25.4327%
27.9022%
23.7494%
24.5738%
19.242%
16.1432%
12.5757%
36.7271%
19.8417%
1.8241%
15.7068%
11.2357%
8.741%
22.3471%
23.5422%
17.4829%
5.596%
1.6909%
5.1364%
5.5129%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.